FDA Investigator Shaquenta Y Perkins

Shaquenta Y Perkins has inspections in 19 countries as of 29 Sep 2023. Shaquenta Y Perkins has collaborated with a combinined 3701 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
138
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Indonesia, China, Taiwan, United Kingdom of Great Britain and Northern Ireland, Germany, Sweden, Australia, Italy, Switzerland, Japan, France, Finland, Netherlands, Thailand, Israel, India, Singapore, Spain
Co-Investigator(s):
A Williams, Ademola O Daramola, Alexandra B Pitkin, Allen F Hall, Amanda N Schaupp, Amy M Cramer, Ana Djurdjevic, Ana M Pietsch, Anderson, Andrace Lde Yampert, Andrea A Branche, Andrews, Arie C Menachem, Armando Chavez, MS, Arsen Karapetyan, Ashley A Mutawakkil, Barbara G Peoples, Bowman, Brandon L Blakely, Brian Ravitch, Bryan A Galvez, Bryce A May, Burnsb, Calvin K Cook, Carolyn E Barney, Carr Sharpe, Catherine J Laufmann, CDR Cecily Jones, CDR Sean T Creighton, Celena Ngo, Celeta S Coves, Charles L Larson, Cheryl D Mccall, Christine I Shaw, Christopher S Genther, Comyar Shoghi, Courtney N Long, Cynthia A Myers, Cynthia L Gorveatt, Daniel J Lahar, Danielle Lyke, Dannie E Rowland, Darrin E Davis, David G Whitman, David Hwang, Davis, Deborah A Greco, Dejon N Harris, Desiree C Iya, Diana M Rand, Doan T Nguyen, PharmD, Donna Ltartaglino Besone, Dustin R Abaonza, Dylan R Jock, Eileen T Dupont, Elizabeth C Ajuzie, Elsa Rivera, Emmanuel A Dimaano, Jr, Evelyn Taha, Felix J Marrero, Finn A Slizza, Finn Sizza (Alex), Francis J Eng, Francisco, Freddy Dtita Nwa, Gabriel M Guevarra, Gail L Katz, Garciam, Gene D Arcy, Geoffrey M Leist, Greg K Keshishyan, Gregson A Joseph, Harperd, Hoover, Iris C Macinnes, James A Lane, James L Finn, James P Stallings, James R Fleckenstein, James W Leonette, James W Plucinski, Janet Pulver, Janete A Eaker, Janete A Oliveira, Jeannie Pradyanata, Jeff M Uriarte, Jeffrey D Sloan, Jeffrey J Thibodeau, Jennifer M Heitz, Jenny L Mccardell, Jeremy H Nguyen, Jeremy L Stukes, Jinnie Kokiatkulkij, Jocelyn C Turner, Jocelyn E Massey, Jocelyn E Sparks, Joey V Quitania, John A Daubenspeck, John A Sciacchitano, Joseph J Hauw, Joshua E Yao, Juanita Banuelos, Juanj N Wu, Juanj Wu, Jude C Dikes, Judy C Nepsa, Ka L Wong, Karen J Bak, Karen M Cruz Arenas, Karen M Rodriguez, Kari M Johansen, Katherine E Jacobitz, Kelly D Sheppard, Kelvin Cheung, Kenneth S Boehnen, Kevin Lee, Kevin N Tran, Kevin T Gerrity, Kimberly M Lichter, Kirtida Patel, Kristen E Rescigno, Kristin M Abaonza, Kwong P Lee, Laiza V Garcia, Lakecha N Lewis, Laurissa S Flowers, Lawrence H Howell, Leeterry Moore, Leighton K Ngai, Leonard H Lavi, Leticia I Romero, Liming Zhang, Linda Linhn Adams, Linda Thai, Lore Fields, Loretta Nemchik, Lori J Silverstein, Marcus F Yambot, Maria Isabetejerodel Rio, Mark C Saale, Mary C Wall, Mary Ewilkerson Brinsko, Matthew J Gretkierewicz, Matthew M Vernon, Maximiano Perez, Mei Chen Mu, Melissa A Zuppe, Melissa J Holz, Michael D Garcia, Michael K Larson, Michael S Call, Michelle J Hines, Minh D Phan, Mizanne E Lewis, Monica J Wilkins, Nancy L Neiger, Natalie J Ayoub, Natalie J Reese, Nathan R Moon, Nianna C Burns, Nicholas C Mendiola, Nicholas L Hunt, Nicole S Williams, Othello G Capangpangan, Paul F Rader, Perry H Gambrell, Phillip L Toy, Rafael A Kaup, Richard Jay Tucker, RS, Richard L Rutherford, Robert C Hoover, Robert S Sweeton, Robert T Lorenz, Rochelle A Rolnik, Rocio Guzman Velazquez, Romero, Ronald L Koller, Sandersk, Sara Jdent Acosta, Sarah A Hassas, Scott J Matsuda, Scott K Zika, Sean P Desbrow, Seema S Singh, Selene T Torres, Shaquenta Yperkinsliming Zhang, Sherri N Rohlf, MD, Sonya L Karsik, Sparky L Bartee, State Agency, Stephen C Smith, Stephen R Souza, Stewarte, Sundy V Sedwick, Sundy Ven, Sunitha K Rajaram, PhD, Tammy Vasquez Hancock, Tawny L Colling, Terrance L Thomas, Thai T Duong, Thanh M Andrews, Thao X Ta, Theresa Kirkham (NMI), Thomas R Beilke, Thomas W Gordon, Timothy P Lafave, Timothy T Kapsala, Tonia L Sawyer, Trudy R Papson, Vashti E Bocker, Vickie L Anderson, Vien Q Le, Vincent F Iacono, Virgilio F Pacio, CSO, Wr Bowman, Xiaojun Yan, Yen Tso Kuo, Yvette E Guillermo, Yvonne C Wilkes, Zhihao Qiu (Peter), PhD

Shaquenta Y Perkins's Documents

Publish Date Document Type Title
February, 2016 FDA 483 Aesthetic Group - Form 483, 2016-02-04
April, 2013 EIR Scantibodies Biologics Inc - EIR, 2013-04-05
March, 2016 EIR Dexcom, Inc. - EIR, 2016-03-29
May, 2014 FDA 483 Respironics California, LLC - Form 483, 2014-05-08
June, 2019 FDA 483 Holymed Products Co., Ltd. - Form 483, 2019-06-19
December, 2016 FDA 483 Lusys Laboratories, Inc. - Form 483, 2016-12-08
January, 2016 FDA 483 Respironics California, LLC - Form 483, 2016-01-15
March, 2016 FDA 483 Dexcom, Inc. - Form 483, 2016-03-29
August, 2019 FDA 483 McRoberts B.V. - Form 483, 2019-08-28
June, 2012 FDA 483 Alere San Diego, Inc. - Form 483, 2012-06-27
April, 2015 EIR Robert Orenstein, DO - EIR, 2015-04-02
April, 2014 FDA 483 Amarc Enterprises, Inc. - Form 483, 2014-04-10
April, 2013 FDA 483 Scantibodies Biologics Inc - Form 483, 2013-04-05
January, 2014 EIR Purvi Mehra, MD - EIR, 2014-01-29
June, 2015 FDA 483 Strata Skin Sciences, Inc. - Form 483, 2015-06-16
June, 2012 EIR Alere San Diego, Inc. - EIR, 2012-06-27
January, 2015 FDA 483 Response Bard Peripheral Vascular Inc - Form 483R, 2015-02-26
January, 2015 FDA 483 Bard Peripheral Vascular Inc - Form 483, 2015-01-05
February, 2015 FDA 483 Lusys Laboratories, Inc. - Form 483, 2015-02-19
May, 2018 FDA 483 Lusys Laboratories, Inc. - Form 483, 2018-05-21
June, 2012 FDA 483 Response Alere San Diego, Inc. - Form 483R, 2012-07-17
September, 2017 FDA 483 Spinal Elements, Inc - Form 483, 2017-09-29
December, 2019 FDA 483 Vacutest Kima SRL - Form 483, 2019-12-13
April, 2015 EIR Dexcom, Inc. - EIR, 2015-04-21
August, 2018 FDA 483 Total Thermal Imaging, Inc. - Form 483, 2018-08-02
July, 2011 FDA 483 Universal Supplement, Inc. - Form 483, 2011-07-29
December, 2019 FDA 483 Caltag Medsystems Ltd - Form 483, 2019-12-11
February, 2011 FDA 483 Aubrey Inc - Form 483, 2011-02-04
January, 2015 EIR Bard Peripheral Vascular Inc - EIR, 2015-01-05
February, 2019 FDA 483 REMIDIO INNOVATIVE SOLUTIONS PVT. LTD - Form 483, 2019-02-07

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more